Entacapone
Tier C — Watch / tradeEntacapone
Targets:COMT
Brand:Comtess, Comtan
Indications (approved):Parkinson's disease
Regional status
Synthetic routes & intermediates5 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| ENTA-001 | 116313-85-0 | 3,4-dihydroxy-5-nitrobenzaldehyde |
| ENTA-002 | 26391-06-0 | 2-cyano-N,N-diethylacetamide |
| ENTA-003 | 618-42-8 | 1-(piperidin-1-yl)ethanone |
| Code | CAS No. | Intermediate |
|---|---|---|
| ENTA-001 | 116313-85-0 | 3,4-dihydroxy-5-nitrobenzaldehyde |
| ENTA-004 | 372-09-8Available | 2-cyanoacetic acid |
| ENTA-005 | 160391-70-8 | (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylic acid |
| ENTA-006 | 1291066-63-1 | (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acryloyl chloride |
| ENTA-007 | 109-89-7 | diethylamine |
| Code | CAS No. | Intermediate |
|---|---|---|
| ENTA-008 | 203861-62-5 | 4-iodo-2-methoxyphenol |
| ENTA-009 | 53793-77-4 | 2-cyano-N,N-diethylacrylamide |
| ENTA-010 | 893419-47-1 | (E)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide |
| ENTA-011 | 857629-78-8 | (E)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylamide |
| Code | CAS No. | Intermediate |
|---|---|---|
| ENTA-002 | 26391-06-0 | 2-cyano-N,N-diethylacetamide |
| ENTA-012 | 91004-48-7 | 3,4-dimethoxy-5-nitrobenzoic acid |
| ENTA-013 | 134610-30-3 | 3,4-dimethoxy-5-nitrobenzoyl chloride |
| ENTA-014 | 1067233-92-4 | (Z)-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethyl-3-hydroxyacrylamide |
| ENTA-015 | 1067233-93-5 | (E)-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylacrylamide |
| Code | CAS No. | Intermediate |
|---|---|---|
| ENTA-001 | 116313-85-0 | 3,4-dihydroxy-5-nitrobenzaldehyde |
| ENTA-002 | 26391-06-0 | 2-cyano-N,N-diethylacetamide |
| ENTA-004 | 372-09-8Available | 2-cyanoacetic acid |
| ENTA-016 | 6635-20-7 | 4-hydroxy-3-methoxy-5-nitrobenzaldehyde |
Frequently asked questions
What are the approved indications of Entacapone?
Approved indications include: Parkinson's disease.
When does the Entacapone patent expire?
No public expiry year is available for Entacapone yet; this page updates once verified.
How many synthesis routes are recorded for Entacapone?
5 synthesis routes are recorded; the shortest is 1 steps with 2.23 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Entacapone intermediates?
1 intermediate CAS of Entacapone are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Entacapone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29